Header Logo

Connection

ROSEMARIE SCHMANDT to In Situ Nick-End Labeling

Back to Details
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about In Situ Nick-End Labeling.
ROSEMARIE SCHMANDT
Connection Strength
0.036
In Situ Nick-End Labeling
  1. EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J Natl Cancer Inst. 2009 Sep 02; 101(17):1193-205.
    View in: PubMed
    Score: 0.020
  2. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. J Natl Cancer Inst. 2006 Nov 01; 98(21):1558-70.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.